Skip to main content

CEA Licenses RNAi Products to New England Biolabs

NEW YORK, Feb. 27 (GenomeWeb News) - CEA Valorisation has licensed its enzymatic synthesis process for double-stranded RNA to New England Biolabs, CEA said today.


The license is non-exclusive.


Financial details were not provided.


CEA is a funded by the French government.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.